prikaz prve stranice dokumenta Biomarker Testing: Piercing the Fog of Alzheimer’s and Related Dementia
  Preuzmi
PDF 586.23 KB
Znanstveni rad - Izvorni znanstveni rad
Biomarker Testing: Piercing the Fog of Alzheimer’s and Related Dementia
Biomedicine Hub, 5 (2020), 3; 19-40. https://doi.org/10.1159/000511233
Horgan, Denis; Nobili, Flavio; Teunissen, Charlotte; Grimmer, Timo; Mitrečić, Dinko; Ris, Laurence; Pirtosek, Zvezdan; Bernini, Chiara; Federico, Antonio; Blackburn, Daniel; Logroscino, Giancarlo; Scarmeas, Nikos

Citirajte ovaj rad

Horgan, D., Nobili, F., Teunissen, C., Grimmer, T., Mitrečić, D., Ris, L. ... Scarmeas, N. (2020). Biomarker Testing: Piercing the Fog of Alzheimer’s and Related Dementia. Biomedicine Hub, 5. (3), 19-40. doi: 10.1159/000511233

Horgan, Denis, et al. "Biomarker Testing: Piercing the Fog of Alzheimer’s and Related Dementia." Biomedicine Hub, vol. 5, br. 3, 2020, str. 19-40. https://doi.org/10.1159/000511233

Horgan, Denis, Flavio Nobili, Charlotte Teunissen, Timo Grimmer, Dinko Mitrečić, Laurence Ris, Zvezdan Pirtosek, et al. "Biomarker Testing: Piercing the Fog of Alzheimer’s and Related Dementia." Biomedicine Hub 5, br. 3 (2020): 19-40. https://doi.org/10.1159/000511233

Horgan, D., et al. (2020) 'Biomarker Testing: Piercing the Fog of Alzheimer’s and Related Dementia', Biomedicine Hub, 5(3), str. 19-40. doi: 10.1159/000511233

Horgan D, Nobili F, Teunissen C, Grimmer T, Mitrečić D, Ris L, i sur.. Biomarker Testing: Piercing the Fog of Alzheimer’s and Related Dementia. Biomedicine Hub [Internet]. 23.11.2020. [pristupljeno 12.11.2024.];5(3):19-40. doi: 10.1159/000511233

D. Horgan, et al., "Biomarker Testing: Piercing the Fog of Alzheimer’s and Related Dementia", Biomedicine Hub, vol. 5, br. 3, str. 19-40, Studeni 2020. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:208441. [Citirano: 12.11.2024.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:105:208441
Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.
Podaci o radu
Naslov (engleski)Biomarker Testing: Piercing the Fog of Alzheimer’s and Related Dementia
AutorDenis Horgan
AutorFlavio Nobili
AutorCharlotte Teunissen
AutorTimo Grimmer
AutorDinko Mitrečić
AutorLaurence Ris
AutorZvezdan Pirtosek
AutorChiara Bernini
AutorAntonio Federico
AutorDaniel Blackburn
AutorGiancarlo Logroscino
AutorNikos Scarmeas
Autorova ustanovaSveučilište u Zagrebu
Medicinski fakultet
(HRVATSKI INSTITUT ZA ISTRAŽIVANJE MOZGA)
Autorova ustanovaSveučilište u Zagrebu
Medicinski fakultet
(KATEDRA ZA HISTOLOGIJU I EMBRIOLOGIJU)
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Temeljne medicinske znanosti
Neuroznanost
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Temeljne medicinske znanosti
Citologija, histologija i embriologija
Sažetak (engleski)
Alzheimer’s disease (AD) and related dementia is one of the growing threats to the sustainability of health and care systems in developed countries, and efforts to find therapies have had scant success. The main reasons for this are lack of efficient therapy, which is linked to too late discovery of the disease itself. With this in mind, biomarkers are recognised as an element which can bring a major contribution to research, helping elucidate the disease and the search for treatments. They are also playing an increasing role in early detection and timely diagnosis, which are considered the principal hopes of effective management in the absence of an effective drug. The current arsenal of biomarkers could already, if more widely deployed, provide an effective minimum service to patients and health systems. A concerted action by policy makers and stakeholders could drive progress in access to AD biomarker testing to provide an optimum service in the medium term. This paper discusses how to improve the use of and access to biomarker testing in the detection and diagnosis of AD and other diseases featuring dementia, and how EU healthcare systems could benefit. It outlines the challenges, lists the achievements to date, and highlights the actions needed to allow biomarker testing to deliver more fully on their potential in AD.
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeZnanstveni rad - Izvorni znanstveni rad
Status objaveObjavljen
Vrsta recenzijeRecenziran
Verzija publikacijeObjavljena verzija rada (izdavačev PDF)
Naslov časopisaBiomedicine Hub
Brojčani podacivol. 5, br. 3, str. 19-40
e-ISSN2296-6870
DOIhttps://doi.org/10.1159/000511233
URN:NBNurn:nbn:hr:105:208441
Datum objave publikacije2020-11-23
URL dokumentahttps://www.karger.com/Article/FullText/511233
Vrsta resursaTekst
Prava pristupaOtvoreni pristup
Uvjeti korištenjaIkona licence Imenovanje-Nekomercijalno-Bez prerada 4.0 međunarodna (CC BY-NC-ND 4.0)
Datum i vrijeme pohrane2021-07-02 09:56:27